|MicroRNA therapeutics: towards a new era for the management of cancer and other diseases|
R Rupaimoole, FJ Slack
Nature reviews Drug discovery 16 (3), 203, 2017
|Paraneoplastic thrombocytosis in ovarian cancer|
RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ...
New England Journal of Medicine 366 (7), 610-618, 2012
|Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer|
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
|miRNA deregulation in cancer cells and the tumor microenvironment|
R Rupaimoole, GA Calin, G Lopez-Berestein, AK Sood
Cancer discovery 6 (3), 235-246, 2016
|Tumour angiogenesis regulation by the miR-200 family|
CV Pecot, R Rupaimoole, D Yang, R Akbani, C Ivan, C Lu, S Wu, HD Han, ...
Nature communications 4 (1), 1-14, 2013
|Hematogenous metastasis of ovarian cancer: rethinking mode of spread|
S Pradeep, SW Kim, SY Wu, M Nishimura, P Chaluvally-Raghavan, ...
Cancer cell 26 (1), 77-91, 2014
|Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer|
L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ...
Molecular systems biology 10 (5), 728, 2014
|Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER|
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 1-13, 2014
|Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression|
R Rupaimoole, SY Wu, S Pradeep, C Ivan, CV Pecot, KM Gharpure, ...
Nature communications 5 (1), 1-13, 2014
|Autocrine effects of tumor-derived complement|
MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ...
Cell reports 6 (6), 1085-1095, 2014
|Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer|
Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ...
Journal of the National Cancer Institute 105 (19), 1485-1495, 2013
|Platelets reduce anoikis and promote metastasis by activating YAP1 signaling|
M Haemmerle, ML Taylor, T Gutschner, S Pradeep, MS Cho, J Sheng, ...
Nature communications 8 (1), 1-15, 2017
|Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers|
G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ...
JNCI: Journal of the National Cancer Institute 107 (7), 2015
|MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer|
Y Sun, L Hu, H Zheng, M Bagnoli, Y Guo, R Rupaimoole, ...
The Journal of pathology 235 (1), 25-36, 2015
|A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer|
SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ...
Nature communications 7 (1), 1-14, 2016
|2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity|
SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ...
Nature communications 5 (1), 1-12, 2014
|Combining anti-miR-155 with chemotherapy for the treatment of lung cancers|
K Van Roosbroeck, F Fanini, T Setoyama, C Ivan, C Rodriguez-Aguayo, ...
Clinical Cancer Research 23 (11), 2891-2904, 2017
|Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis|
HP Joshi, IV Subramanian, EK Schnettler, G Ghosh, R Rupaimoole, ...
Proceedings of the National Academy of Sciences 111 (14), 5331-5336, 2014
|Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis|
R Rupaimoole, J Lee, M Haemmerle, H Ling, RA Previs, S Pradeep, ...
Cell reports 13 (11), 2395-2402, 2015
|MicroRNA therapeutics: principles, expectations, and challenges|
R Rupaimoole, HD Han, G Lopez-Berestein, AK Sood
Chinese journal of cancer 30 (6), 368, 2011